Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

Merck Serono Launches RebiSmart™, First Electronic Injection Device For Delivery of Multiple Sclerosis Treatment Rebif®

Posted Nov 17 2009 10:20pm
Merck Serono Launches RebiSmart™, First Electronic Injection Device For Delivery of Multiple Sclerosis Treatment Rebif®

* RebiSmart™ is designed to improve ease of handling and usage and introduces the potential for improved treatment adherence for multiple sclerosis patients
* First launch of RebiSmart™ together with recently approved multidose cartridges of the new formulation of Rebif® in the European Union and Canada

Geneva, Switzerland, June 24, 2009 – Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today the launch of the innovative individually adjustable electronic injection device RebiSmart™ for the self-administration of Rebif® (interferon beta-1a), the company’s disease-modifying drug used to treat relapsing forms of multiple sclerosis (MS). RebiSmart™ is the first device of its kind in this indication and was specifically designed for ease of handling and use. The unique features of RebiSmart™ also introduce the potential for improved treatment adherence, helping patients receive the full benefit from their treatment.

Click here to continue reading.

Meanwhile, if you are not yet registered to receive our weekly MS related e-Newsletter, called "Stu's Views and MS Related News", please click here to register. It will take less than 30 seconds to complete this form. - Thank you
============================================
Post a comment
Write a comment:

Related Searches